Medicaid Pharmaceutical Policy Document Database, 2005–2020
Principal Investigator(s): View help for Principal Investigator(s) Janet Currie, Yale University; Kate Musen, Columbia University
Version: View help for Version V1
| Name | File Type | Size | Last Modified |
|---|---|---|---|
|
|
application/zip | 18.8 MB | 10/09/2025 01:09:PM |
|
|
application/zip | 43.7 MB | 10/09/2025 12:34:PM |
|
|
application/zip | 20.6 MB | 10/09/2025 12:20:PM |
|
|
application/zip | 124.6 MB | 10/09/2025 01:24:PM |
|
|
application/zip | 77.8 MB | 10/09/2025 12:21:PM |
|
|
application/zip | 333.2 MB | 10/09/2025 12:24:PM |
|
|
application/zip | 27.1 MB | 10/09/2025 12:21:PM |
|
|
application/zip | 73.5 MB | 10/09/2025 12:21:PM |
|
|
application/zip | 86 MB | 10/09/2025 12:21:PM |
|
|
application/zip | 168.5 MB | 10/09/2025 12:21:PM |
- Total of 50 records. Records per page
- « previous Page of 5
- next »
Project Citation:
Currie, Janet, and Musen, Kate. Medicaid Pharmaceutical Policy Document Database, 2005–2020. Ann Arbor, MI: Inter-university Consortium for Political and Social Research [distributor], 2025-10-09. https://doi.org/10.3886/E238714V1
Project Description
Summary:
View help for Summary
This database provides a hand-collected archive of state Medicaid pharmaceutical policy documents from 2005–2020, compiled to establish accurate timelines of pediatric antipsychotic prior authorization policies. This collection includes primary source materials obtained from state Medicaid program records, including prescription drug lists, Drug Utilization Review Board and Pharmacy & Therapeutics Committee meeting minutes, provider manuals, policy memoranda, and related administrative records.
Although the database was developed to identify the implementation dates of antipsychotic prior authorization policies for children, the underlying documents provide a broad view of state Medicaid drug coverage and utilization management, including preferred drug lists, step therapy requirements, and pharmacy benefit carve-outs. As such, the collection offers a detailed record of how states administered and revised their Medicaid pharmaceutical programs over two decades. Many of these documents were obtained through Freedom of Information Act (FOIA) and Public Record Act requests or recovered from the Internet Archive’s Wayback Machine.
Although the database was developed to identify the implementation dates of antipsychotic prior authorization policies for children, the underlying documents provide a broad view of state Medicaid drug coverage and utilization management, including preferred drug lists, step therapy requirements, and pharmacy benefit carve-outs. As such, the collection offers a detailed record of how states administered and revised their Medicaid pharmaceutical programs over two decades. Many of these documents were obtained through Freedom of Information Act (FOIA) and Public Record Act requests or recovered from the Internet Archive’s Wayback Machine.
Funding Sources:
View help for Funding Sources
NOMIS Foundation;
National Science Foundation (DGE2036197)
Scope of Project
Geographic Coverage:
View help for Geographic Coverage
United States
Time Period(s):
View help for Time Period(s)
2005 – 2020
Data Type(s):
View help for Data Type(s)
images: photographs, drawings, graphical representations;
other;
text
Related Publications
Published Versions
Report a Problem
Found a serious problem with the data, such as disclosure risk or copyrighted content? Let us know.
This material is distributed exactly as it arrived from the data depositor. ICPSR has not checked or processed this material. Users should consult the investigator(s) if further information is desired.